Who Should Avoid Melatonin for Sleep
Pregnant and breastfeeding women should not take melatonin due to lack of safety data, and major clinical guidelines recommend against using melatonin for chronic insomnia in adults regardless of population. 1, 2, 3
Primary Guideline Recommendations
The American Academy of Sleep Medicine (2017) and the VA/DOD (2020) both suggest against using melatonin for the treatment of chronic insomnia disorder in adults 1, 2. These are weak recommendations against use, meaning the harms are considered to approximately equal or outweigh the benefits for treating insomnia.
Specific Populations Who Should Avoid Melatonin
Absolute Contraindications:
- Pregnant women - No human safety studies exist; should not use exogenous melatonin 3
- Breastfeeding women - Insufficient data on safety; should avoid use 3
Populations Requiring Caution (Insufficient Safety Data):
- Pre-adolescent children and adolescents - Long-term safety not established, requires further investigation before routine use 3
- Patients with epilepsy - Concern raised but insufficient robust data to definitively assess risk 4
- Patients with asthma - Concern raised but insufficient robust data to definitively assess risk 4
Clinical Context and Nuances
The guidelines' recommendation against melatonin is based on very low quality evidence showing harms outweigh benefits for chronic insomnia 1. This doesn't mean melatonin is dangerous—safety studies show it's generally well-tolerated with only mild adverse effects (drowsiness 28.8%, headache 25.1%) 4, 5. Rather, it means melatonin is simply not effective enough for treating chronic insomnia compared to other options.
Common Pitfalls:
- Melatonin is not FDA-approved for insomnia and exists as a dietary supplement, creating ambiguity in proper usage 6
- Most people use it incorrectly (2mg 30 minutes before bed), when evidence suggests 4mg taken 3 hours before desired bedtime may be more effective 7
- It's widely perceived as safe (78.2% of users) despite guideline recommendations against its use for insomnia 5
What Guidelines Actually Recommend Instead:
For chronic insomnia in adults, guidelines suggest:
- Cognitive behavioral therapy for insomnia (CBT-I) as first-line treatment 2
- If pharmacotherapy needed: low-dose doxepin (3-6mg) or nonbenzodiazepine receptor agonists 2
- Ramelteon (melatonin receptor agonist) over melatonin itself 1
The evidence is clear that while melatonin won't cause serious harm in most adults, it simply doesn't work well enough for chronic insomnia to justify recommending it over proven alternatives.